Neoangiogenesis and p53 protein in lung cancer: Their prognostic role and their relation with vascular endothelial growth factor (VEGF) expression

British Journal of Cancer

Volumn 75, Issue 9, 1997, Pages 1295-1301

  Fontanini, G ^a,b   Vignati, S ^a   Lucchi, M ^a   Mussi, A ^a   Calcinai, A ^a   Boldrini, L ^c   Chine S ^a   Silvestri, V ^a   Angeletti, C A ^a   Basolo, F ^a   Bevilacqua, G ^a  

^a UNIVERSITY OF PISA   (Italy)

^b Institute of Pathology   (Italy)

^c NONE

Author keywords

Microvessel count; Non small cell lung cancer; p53; Vascular endothelial growth factor

Indexed keywords

PROTEIN P53; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; CANCER SURVIVAL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG CARCINOMA; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR VASCULARIZATION;

EID: 8244233169     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1997.220     Document Type: Article

References (34)

1. Barnhill RL, Fandrey K, Levy MA, Mihm MC and Hyman B (1992) Angiogenesis and tumor progression of melanoma: quantitation of vascularity in melanocytic nevi and cutaneous melanoma. Lab Invest 67: 331-337
2. Bennett WP, Colby TV, Travis WT, Borkowski A, Jones KT, Lane DP, Metcalf KA, Samet JM, Takeshima Y, du JK, Vahakangas KH, Soini Y, Paakko P, Welsh JA, Trump BF and Harris CC (1993) p53 protein accumulates frequently in early bronchial neoplasia. Cancer Res 53: 4817-4822
3. Dameron KM, Volpert OG, Tainsky MA and Buck N (1994) Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1. I. Science 265: 1582-1584
4. Fontanini G, Macchiarini P, Pepe S, Ruggiero A, Hardin M, Bigini D, Vignati S, Pingitore R and Angeletti CA (1992) The expression of proliferating cell nuclear antigen in paraffin sections of peripheral node-negative non-small cell lung cancer. Cancer 70: 1520-1527
5. Fontanini G, Vignati S, Bigini D, Merlo GR, Ribechini A, Angeletti CA, Basolo F, Pingitore R and Bevilacqua G (1994) Human non-small cell lung cancer: p53 protein accumulation is an early event and persists during metastatic progression. J Pathol 174: 23-31
6. Fontanini G, Bigini D, Vignati S, Basolo F, Mussi A, Lucchi M, Chiné S, Angeletti CA and Bevilacqua G (1995a) Microvessel count predicts metastatic disease and survival in non-small cell lung cancer. J Pathol 73: 57-63
7. Fontanini G, Vignati S, Bigini D, Mussi A, Lucchi M, Angeletti CA, Basolo F and Bevilacqua G (1995b) Bcl-2 protein: a prognostic factor inversely correlated to p53 in non-small-cell lung cancer. Br J Cancer 72: 1003-1007
8. Gasparini G and Harris AL (1995) Clinical importance of the determination of tumor angiogenesis in breast carcinoma: much more than a new prognostic tool. J Clin Oncol 13: 765-782
9. Gasparini G, Weidner N, Maluta S, Pozza F, Mezzetti M, Testolin A and Bevilacqua P (1993) Intratumoral microvessel density and p53 protein: correlation with metastasis in head-and-neck squamous-cell carcinoma. Int J Cancer 55: 739-744
10. Harris CC and Hollstein M (1993) Clinical implications of the p53 tumor-suppressor gene. N Engl J Med 329: 1318-1326
11. Hollingsworth HC, Kohn EC, Steimberg SM, Rothemberg ML and Merino MJ (1995) Tumor angiogenesis in advanced stage ovarian carcinoma. Am J Pathol 147: 33-41
12. Kieser A, Weich HA, Brandner G, Marmé D and Kolch W (1994) Mutant p53 potentiates protein kinase C induction of vascular endothelial growth factor expression. Oncogene 9: 964-969
13. Lane DP (1990) Mutations of the p53 gene and accumulation of the p53 protein: common steps found in the majority of human cancers. In Accomplishment in Cancer Research. Fortner JG and Rhoads JE (eds) pp. 252-256. Lippincott: Philadelphia
14. Lee JS, Yoon A, Kalapurakal SK, Ro JY, Lee J, Tu N, Hittelman WN and Hong WK (1995) Expression of p53 oncoprotein in non-small-cell lung cancer: a favorable prognostic factor. J Clin Oncol 13: 1893-1903
15. Li VW, Folkert RD, Watanabe H, Yu C, Rupnick M, Barnes P, Scott RM, Black PM, Sallan SE and Folkman J (1994) Mierovessel count and cerebrospinal fluid basic fibroblast growth factor in children with brain tumors, Lancet 334: 82-86
16. Macchiarini P, Fontanini G, Hardin JM, Squartini F and Angeletti CA (1992) Relation of neovascularisation to metastasis of non-small-cell lung cancer. Lancet 340: 45-46
17. Mattern J, Koomagi R and Volm M (1996) Association of vascular endothelial growth factor expression with intratumoral microvessel density and tumor cell proliferation in human epidermoid lung carcinoma. Br J Cancer 73: 931-934
18. Mountain CF (1986) A new international staging system for lung cancer. Chest 89: 225s-233s
19. Mukhopadhyay D, Tsiokas L and Sukhatme V (1995) Wild-type P53 and v-Src opposing influence on human vascular endothelial growth factor gene expression. Cant er Res 57: 6161-6165
20. Olivarez D, Ulbrigh T, Deriese W, Foster R, Reister T, Einhorn L and Sledge G (1994) Neovascularization in clinical stage A testicular germ cell tumor: prediction of metastatic disease. Cancer Res 54: 2800-2802
21. Quinlan DC, Davidson AS, Summers CL, Warden HE and Doshi HM (1992) Accumulation of p53 correlates with a poor prognosis in human lung cancer. Cancer Rex 52: 4828-4831
22. Rastinejad F, Polverini PJ and Bouck NP (1989) Regulation of the activity of a new inhibitor of angiogenesis by a cancer suppressor gene. Cell 56: 345-355
23. Saclarides TJ, Speziale NJ, Drab E, Szeluga DJ and Rubin DB (1994) Tumor angiogenesis and rectal carcinoma. Dis Colon Rectum 37: 921-926
24. Slebos RJC, Kibbelaar RE, Dalesio O, Kooistra A, Stam J, Meijer J, Wagenaar SS, Vanderschueren RGJRA, Van Zandwijk N, Volter JN, Bos JR and Rodenhuis S (1991) K-ras oncogene activation as a prognostic marker in adenocarcinoma of the lung. N Engl J Med 324: 1084-1090
25. Sozzi G, Miozzo M, Denghi R, Pilotti S, Cariani CT, Pastorino U, Delia Porta G and Pierotti MA (1992) Deletions of 17p and p53 mutations in preneoplastic lesion of the lung. Cancer Res 52: 6079-6082
26. Sundaresan V, Ganly P, Hasleton P, Rudd R, Sinha G, Bleehen NM and Rabbitts P (1992) p53 and chromosome 3 abnormalities, characteristic of malignant lung tumours, are detectable in preinvasive lesions of the bronchus. Oncogene 7: 1989-1997
27. Tateishi M, Ishida T, Mitsudomi T, Kanero S and Sugimachi K (1991) Prognostic value of c-erb-B protein expression in human lung adenocarcinoma and squamous cell carcinoma. Eur J Cancer 27: 1372-1375
28. Uaeger TM, Weidner N, Chew K, Moore DH, Kerschmann RL, Waldmann RL and Carroll PR (1994) Tumor angiogenesis and lymph node metastases in invasive bladder carcinoma. J Urol 151: 348 (abstract)
29. Van Meier EG, Polverini PJ, Chazin VR, Su Huang HJ, De Tribolet N and Cavenee WK (1994) Release of an inhibitor of angiogenesis upon induction of wild-type p53 expression in glioblastoma cells. Nature Genet 8: 171-176
30. Weidner N, Carroll PR, Flax J, Blumenfeld W and Folkman J (1993) Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am J Pathol 143: 401-409
31. Weidner N, Semple JP, Welch WR and Folkman J (1991) Tumor angiogenesis and metastasis - correlation in invasive breast carcinoma. N Engl J Med 324: 1-8
32. Weidner N and Folkman J (1996) Tumoral vascularity as a prognostic factor in cancer. In Important Advances in Oncology, De Vita VT, Hellmann S, Rosenberg SA (eds) pp. 167-190. Lippincott-Raven: Philadelphia
33. World Health Organization (1982) The World Health Organization. Histological typing of lung tumours. Am J Clin Pathol 77: 123-136
34. Yamasaki K, Abe S, Takekawa WM, Sukou N, Watanabe N, Ogura S, Nakajima J, Isobe H, Inoue K and Kawakami JWM (1994) Tumor angiogenesis in human lung adenocarcinoma. Cancer 54: 2245-2250